Cargando…
Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection
The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has severely impacted human health and the health management system globally. The ongoing pandemic has required the development of more effective diagnostic strategies for restricti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414050/ https://www.ncbi.nlm.nih.gov/pubmed/36016088 http://dx.doi.org/10.3390/vaccines10081200 |
_version_ | 1784775899768422400 |
---|---|
author | Pandey, Satish Kumar Mohanta, Girish C. Kumar, Vinod Gupta, Kuldeep |
author_facet | Pandey, Satish Kumar Mohanta, Girish C. Kumar, Vinod Gupta, Kuldeep |
author_sort | Pandey, Satish Kumar |
collection | PubMed |
description | The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has severely impacted human health and the health management system globally. The ongoing pandemic has required the development of more effective diagnostic strategies for restricting deadly disease. For appropriate disease management, accurate and rapid screening and isolation of the affected population is an efficient means of containment and the decimation of the disease. Therefore, considerable efforts are being directed toward the development of rapid and robust diagnostic techniques for respiratory infections, including SARS-CoV-2. In this article, we have summarized the origin, transmission, and various diagnostic techniques utilized for the detection of the SARS-CoV-2 virus. These higher-end techniques can also detect the virus copy number in asymptomatic samples. Furthermore, emerging rapid, cost-effective, and point-of-care diagnostic devices capable of large-scale population screening for COVID-19 are discussed. Finally, some breakthrough developments based on spectroscopic diagnosis that could revolutionize the field of rapid diagnosis are discussed. |
format | Online Article Text |
id | pubmed-9414050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94140502022-08-27 Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection Pandey, Satish Kumar Mohanta, Girish C. Kumar, Vinod Gupta, Kuldeep Vaccines (Basel) Review The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has severely impacted human health and the health management system globally. The ongoing pandemic has required the development of more effective diagnostic strategies for restricting deadly disease. For appropriate disease management, accurate and rapid screening and isolation of the affected population is an efficient means of containment and the decimation of the disease. Therefore, considerable efforts are being directed toward the development of rapid and robust diagnostic techniques for respiratory infections, including SARS-CoV-2. In this article, we have summarized the origin, transmission, and various diagnostic techniques utilized for the detection of the SARS-CoV-2 virus. These higher-end techniques can also detect the virus copy number in asymptomatic samples. Furthermore, emerging rapid, cost-effective, and point-of-care diagnostic devices capable of large-scale population screening for COVID-19 are discussed. Finally, some breakthrough developments based on spectroscopic diagnosis that could revolutionize the field of rapid diagnosis are discussed. MDPI 2022-07-28 /pmc/articles/PMC9414050/ /pubmed/36016088 http://dx.doi.org/10.3390/vaccines10081200 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pandey, Satish Kumar Mohanta, Girish C. Kumar, Vinod Gupta, Kuldeep Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title | Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title_full | Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title_fullStr | Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title_full_unstemmed | Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title_short | Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection |
title_sort | diagnostic tools for rapid screening and detection of sars-cov-2 infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414050/ https://www.ncbi.nlm.nih.gov/pubmed/36016088 http://dx.doi.org/10.3390/vaccines10081200 |
work_keys_str_mv | AT pandeysatishkumar diagnostictoolsforrapidscreeninganddetectionofsarscov2infection AT mohantagirishc diagnostictoolsforrapidscreeninganddetectionofsarscov2infection AT kumarvinod diagnostictoolsforrapidscreeninganddetectionofsarscov2infection AT guptakuldeep diagnostictoolsforrapidscreeninganddetectionofsarscov2infection |